This Biotech Risk-Taker Created Moderna. Now He's Harnessing AI.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 26 2024
0mins
Should l Buy SHOP?
Source: Barron's
Flagship Pioneering Overview: Flagship Pioneering, a leading venture creation firm in biotechnology, has raised $3.6 billion to enhance drug discovery using AI and manage early-stage clinical trials, distinguishing itself by having in-house scientists develop multiple companies under its umbrella, including the well-known Moderna.
Investment Strategy and Future Plans: The firm plans to invest in initiatives like Pioneering Medicines for managing partnerships and early-phase trials, as well as Pioneering Intelligence to apply machine learning in drug development, while continuing its focus on sustainable agriculture and novel protein-derived medical treatments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SHOP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SHOP
Wall Street analysts forecast SHOP stock price to rise
31 Analyst Rating
18 Buy
13 Hold
0 Sell
Moderate Buy
Current: 105.440
Low
140.00
Averages
180.62
High
200.00
Current: 105.440
Low
140.00
Averages
180.62
High
200.00
About SHOP
Shopify Inc. (Shopify) is a Canada-based global commerce company. The Company provides essential Internet infrastructure for commerce, offering tools to start, grow, market and manage a retail business of any size. It provides platforms and services that are engineered and delivers a shopping experience for consumers online, in store and everywhere in between. Its software enables merchants to run their business across all of their sales channels, including Web and mobile storefronts, physical retail locations, social media storefronts, and marketplaces. The Company's Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting, and access financing, all from one integrated back office. The Shopify's platform operates across 175 countries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Opendoor Technologies Stock Price Fluctuation Analysis
- Stock Price Volatility: Opendoor's shares surged from under $1 to $10.87 in 2025, currently trading just above $5, indicating a cautious market outlook on its future performance.
- Management Changes: The return of co-founders Keith Rabois and Eric Wu to the board, along with the appointment of former Shopify COO Kaz Nejatian as CEO, has positively influenced investor sentiment, suggesting potential for a successful turnaround strategy.
- Profitability Challenges: Despite Opendoor's efforts to utilize generative AI to cut costs, analysts project a narrowing of losses from negative EPS of $0.25 to $0.15 in 2026, highlighting ongoing difficulties in achieving profitability.
- Market Environment Impact: High interest rates have stifled housing market recovery, and shareholder dilution risks may hinder Opendoor's stock from surpassing $10 in the near term, prompting investors to approach future investments with caution.
See More
Opendoor Stock Volatility and Challenges Ahead
- Stock Price Fluctuations: Opendoor Technologies saw its shares soar last fall due to investor Eric Jackson's $82 price target, rising from $5 to $10.87, but has since retreated to just above $5, indicating waning market confidence in its future prospects.
- Management Changes Impact: The return of co-founders Keith Rabois and Eric Wu to the board, along with Kaz Nejatian as the new CEO, initially sparked investor enthusiasm; however, the ongoing high-interest-rate environment continues to hinder a recovery in the housing market, limiting Opendoor's growth potential.
- Profitability Challenges: While Opendoor is leveraging AI to optimize its cost structure, analysts project a narrowing of per-share losses from $0.25 to $0.15 in 2026, yet achieving profitability remains elusive, highlighting the ongoing challenges the company faces.
- Shareholder Dilution Risks: A complex series of transactions last year, including warrant distributions and convertible note redemptions, may lead to future shareholder dilution, further constraining Opendoor's stock price upside, prompting investors to carefully assess its investment value.
See More
Shopify Reports Strong Q1 but Soft Outlook Weighs on Shares
- Significant Revenue Growth: Shopify's Q1 revenue surged 34% year-over-year to approximately $3.2 billion, accelerating from 31% growth in Q4 2025, indicating strong performance in the e-commerce sector despite a tepid market reaction.
- Transaction Volume Milestone: The platform's gross merchandise volume (GMV) reached $100.7 billion, up 35% year-over-year, reflecting Shopify's success in attracting merchants and consumers, yet future growth expectations have softened.
- Profitability Gains: Operating income nearly doubled to $382 million from $203 million year-over-year, with free cash flow at $476 million maintaining a 15% margin, showcasing a robust foundation in profitability.
- Uncertain Market Outlook: Despite a strong Q1, management's guidance for Q2 revenue growth at a
See More
Shopify and Others Tumble as Cathie Wood Buys on Dip
- Shopify Earnings Performance: Shopify reported a 34% revenue increase to $102.3 million in Q1, driven by a 35% rise in GMV, but a cautious outlook led to a 16% stock drop, indicating market concerns over its high valuation.
- Intellia's Positive Outlook: Intellia Therapeutics saw only a 4% decline, with Canaccord raising its price target from $48 to $58, reflecting confidence in positive clinical data for its CRISPR-based therapies, highlighting ongoing interest in gene editing.
- GeneDX's Disappointing Results: GeneDX's stock plummeted 49% after Q1 revenue grew only 17% to $102.3 million, falling short of the expected 30% growth, and the company lowered its 2026 revenue forecast to $475 million-$490 million, indicating significant business challenges ahead.
- Cathie Wood's Buying Strategy: Despite the negative market sentiment, Cathie Wood's Ark Invest increased its positions in Shopify, Intellia, and GeneDX during the downturn, suggesting her optimism about their long-term potential, which may attract other investors' attention.
See More
SHOPIFY INC: OPPENHEIMER LOWERS TARGET PRICE FROM $200 TO $175
- Company Update: Shopify Inc. has made a significant adjustment to its stock target price.
- Target Price Change: The new target price is set at $175, down from the previous $200.
See More
ARK Invest Increases Shopify Holdings Amid Growth Concerns
- Increased Holdings: Cathie Wood's ARK Invest added 255,804 shares of Shopify across its ETFs, demonstrating confidence in the company despite a more than 15% stock drop due to weak growth outlook, indicating a strategic commitment to Shopify's long-term potential.
- Strong Earnings Report: Shopify reported a 34% year-on-year revenue increase in Q1, reaching $3.17 billion, surpassing analysts' expectations of $3.09 billion, showcasing robust performance in the e-commerce sector despite tougher year-over-year comparisons ahead.
- Shifting Market Sentiment: Retail sentiment on Stocktwits shifted from 'bullish' to 'extremely bullish', with message volume surging 325% in 24 hours, reflecting investor optimism about Shopify's future performance, even as the stock has declined over 33% year-to-date.
- Analyst Rating Adjustments: Jefferies and Piper Sandler lowered their price targets for Shopify to $140 and $150 respectively while maintaining 'Hold' and 'Overweight' ratings, indicating concerns about short-term growth that could weigh on the stock price moving forward.
See More
Opendoor Technologies Stock Price Fluctuation Analysis
- Stock Price Volatility: Opendoor's shares surged from under $1 to $10.87 in 2025, currently trading just above $5, indicating a cautious market outlook on its future performance.
- Management Changes: The return of co-founders Keith Rabois and Eric Wu to the board, along with the appointment of former Shopify COO Kaz Nejatian as CEO, has positively influenced investor sentiment, suggesting potential for a successful turnaround strategy.
- Profitability Challenges: Despite Opendoor's efforts to utilize generative AI to cut costs, analysts project a narrowing of losses from negative EPS of $0.25 to $0.15 in 2026, highlighting ongoing difficulties in achieving profitability.
- Market Environment Impact: High interest rates have stifled housing market recovery, and shareholder dilution risks may hinder Opendoor's stock from surpassing $10 in the near term, prompting investors to approach future investments with caution.
See More
Opendoor Stock Volatility and Challenges Ahead
- Stock Price Fluctuations: Opendoor Technologies saw its shares soar last fall due to investor Eric Jackson's $82 price target, rising from $5 to $10.87, but has since retreated to just above $5, indicating waning market confidence in its future prospects.
- Management Changes Impact: The return of co-founders Keith Rabois and Eric Wu to the board, along with Kaz Nejatian as the new CEO, initially sparked investor enthusiasm; however, the ongoing high-interest-rate environment continues to hinder a recovery in the housing market, limiting Opendoor's growth potential.
- Profitability Challenges: While Opendoor is leveraging AI to optimize its cost structure, analysts project a narrowing of per-share losses from $0.25 to $0.15 in 2026, yet achieving profitability remains elusive, highlighting the ongoing challenges the company faces.
- Shareholder Dilution Risks: A complex series of transactions last year, including warrant distributions and convertible note redemptions, may lead to future shareholder dilution, further constraining Opendoor's stock price upside, prompting investors to carefully assess its investment value.
See More
Shopify Reports Strong Q1 but Soft Outlook Weighs on Shares
- Significant Revenue Growth: Shopify's Q1 revenue surged 34% year-over-year to approximately $3.2 billion, accelerating from 31% growth in Q4 2025, indicating strong performance in the e-commerce sector despite a tepid market reaction.
- Transaction Volume Milestone: The platform's gross merchandise volume (GMV) reached $100.7 billion, up 35% year-over-year, reflecting Shopify's success in attracting merchants and consumers, yet future growth expectations have softened.
- Profitability Gains: Operating income nearly doubled to $382 million from $203 million year-over-year, with free cash flow at $476 million maintaining a 15% margin, showcasing a robust foundation in profitability.
- Uncertain Market Outlook: Despite a strong Q1, management's guidance for Q2 revenue growth at a
See More
Shopify and Others Tumble as Cathie Wood Buys on Dip
- Shopify Earnings Performance: Shopify reported a 34% revenue increase to $102.3 million in Q1, driven by a 35% rise in GMV, but a cautious outlook led to a 16% stock drop, indicating market concerns over its high valuation.
- Intellia's Positive Outlook: Intellia Therapeutics saw only a 4% decline, with Canaccord raising its price target from $48 to $58, reflecting confidence in positive clinical data for its CRISPR-based therapies, highlighting ongoing interest in gene editing.
- GeneDX's Disappointing Results: GeneDX's stock plummeted 49% after Q1 revenue grew only 17% to $102.3 million, falling short of the expected 30% growth, and the company lowered its 2026 revenue forecast to $475 million-$490 million, indicating significant business challenges ahead.
- Cathie Wood's Buying Strategy: Despite the negative market sentiment, Cathie Wood's Ark Invest increased its positions in Shopify, Intellia, and GeneDX during the downturn, suggesting her optimism about their long-term potential, which may attract other investors' attention.
See More
SHOPIFY INC: OPPENHEIMER LOWERS TARGET PRICE FROM $200 TO $175
- Company Update: Shopify Inc. has made a significant adjustment to its stock target price.
- Target Price Change: The new target price is set at $175, down from the previous $200.
See More
ARK Invest Increases Shopify Holdings Amid Growth Concerns
- Increased Holdings: Cathie Wood's ARK Invest added 255,804 shares of Shopify across its ETFs, demonstrating confidence in the company despite a more than 15% stock drop due to weak growth outlook, indicating a strategic commitment to Shopify's long-term potential.
- Strong Earnings Report: Shopify reported a 34% year-on-year revenue increase in Q1, reaching $3.17 billion, surpassing analysts' expectations of $3.09 billion, showcasing robust performance in the e-commerce sector despite tougher year-over-year comparisons ahead.
- Shifting Market Sentiment: Retail sentiment on Stocktwits shifted from 'bullish' to 'extremely bullish', with message volume surging 325% in 24 hours, reflecting investor optimism about Shopify's future performance, even as the stock has declined over 33% year-to-date.
- Analyst Rating Adjustments: Jefferies and Piper Sandler lowered their price targets for Shopify to $140 and $150 respectively while maintaining 'Hold' and 'Overweight' ratings, indicating concerns about short-term growth that could weigh on the stock price moving forward.
See More
